Treating type 2 diabetes: targeting the many causative factors.
Sutherland
John E
JE
Northeast Iowa Family Practice Residency Program, University of Iowa College of Medicine, 2055 Kimball Ave, Waterloo, IA 50702, USA. jsutherl@neimef.org
Hoehns
James D
JD
D000465:Algorithms; D001645:Biguanides / Q000009:adverse effects / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000628:therapy; D004359:Drug Therapy, Combination; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007328:Insulin / Q000009:adverse effects / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000627:therapeutic use; D045162:Thiazolidinediones / Q000009:adverse effects / Q000627:therapeutic use
D001645:Biguanides; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; D045162:Thiazolidinediones